ロード中...
The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective
Over the past decade, the development of high-efficacy disease-modifying therapies (DMTs) has been responsible for more effective management of relapsing-remitting multiple sclerosis (RRMS). However, the gaps in optimal care for this complex disease remain. Alemtuzumab (Lemtrada®) is a highly effica...
保存先:
| 出版年: | Ther Adv Neurol Disord |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7498833/ https://ncbi.nlm.nih.gov/pubmed/32973927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286420954119 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|